|Ticker||Company||Sector||% Price Change Past 10 Days||Previous Close||TradingView Rating|
|AVXL||Anavex Life Sciences Corp.||Healthcare & Biotech||+39%||$17.34||Buy|
|KIN||Kindred Biosciences Inc.||Healthcare & Biotech||+35%||$6.34||Strong Buy|
- TradingView’s 1 Day Technical Analysis chart has KIN rated as a Strong Buy and AVXL as a Buy
- Zacks has both AVXL and KIN listed within the Bottom 15% in their Industry Rankings and both rated as a Holds
- TipRanks.com has both AVXL and KIN rated as a Strong Buy. Join TipRanks.com to get all the Strong Buys, Inside Trades and more...
- Yahoo! Finance has both AVXL and KIN showing a Bullish short-term Outlook
- Barchart has both AVXL and KIN rated as a Strong Buy